Drugs & Targets Carrum Health and AccessHope partner to increase access to cost-effective cancer expertise November 04, 2022Vol.48 No.40
Drugs & Targets FDA approves Imjudo in combination with Imfinzi for unresectable hepatocellular carcinoma October 28, 2022Vol.48 No.39
Drugs & Targets FDA denies marketing application for menthol e-cigarettes October 28, 2022Vol.48 No.39
Drugs & Targets FDA publishes final guidance on drug development for AML October 21, 2022Vol.48 No.38
Drugs & Targets FDA publishes draft guidance on characterizing, collecting, and reporting immune-mediated adverse reactions October 21, 2022Vol.48 No.38
Drugs & Targets FDA publishes draft guidance on tissue agnostic drug development in oncology October 21, 2022Vol.48 No.38
Drugs & Targets Pluvicto receives positive CHMP opinion for prostate cancer October 21, 2022Vol.48 No.38
Drugs & Targets Libtayo receives positive CHMP opinion for advanced cervical cancer October 21, 2022Vol.48 No.38
